A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People >/= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection,
Role: Investigator,
Gilead Sciences, Inc,
(07/2024 - 07/2025)
Status: Approved
Internal
Study on the use of COVID-19 monoclonal antibodies in solid organ transplant patients,
Role: PI,
LLU Dept. of Medicine,
(05/2023)
Status: Approved
Detection of alloreactive T lymphocyte clones to predict acute rejection after kidney transplantation,
Role: Co-Investigator,
LLU School of Medicine,
(04/2023 - 03/2026)
Status: Awarded
Characterization of risk factors, treatment, clinical outcomes, and burden of cytomegalovirus (CMV) infections in solid organ transplant (SOT) recipients,
Role: PI,
LLU Dept. of Medicine,
(03/2023)
Status: Approved
Loma Linda International Surveillance Network (LLISN),
Role: Investigator,
LLU Basic Science,
(04/2021)
Status: Approved
Non-Profit Organization
Integration of donor-derived cell-free DNA with HLA-DR+TNFR2+ regulatory T cell in the prediction of acute rejection and graft function after kidney transplantation,
Role: Investigator,
American Society of Transplant Surgeons,
(08/2024 - 08/2025)
Status: Approved